Eli Lilly Is Building a Weight Loss Drug for Every Kind of Patient
The company's peers in the pharmaceutical industry should be worried.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Health & Medicine
New obesity definitions reveal ill health more accurately than body mass index
Traditionally, obesity has been classified primarily using BMI, a measure of weight relative to height that provides limited information about whether excess fat is actually affecting a person's…
Insomnia drug lemborexant reduces the gap between perceived and actual sleep
A recent study reveals that the insomnia drug lemborexant helps align how well patients think they slept with actual sleep data.
Eli Lilly Is Building a Weight Loss Drug for Every Kind of Patient
Key PointsEli Lilly has a broad pipeline of weight-loss products that will help it maintain its lead in this area.
Check Your Carton: FDA Elevates Egg Recall to Highest Level After Salmonella Outbreak
The health agency’s most serious designation follows last month’s recall of 1.6 million dozen eggs now linked to 98 illnesses in 17 states.